338
Views
10
CrossRef citations to date
0
Altmetric
Articles

Ethical Challenges in Designing, Conducting, and Reporting Research to Improve the Mental Health of Pregnant Women: The Voices of Investigators and IRB Members

, , , &

REFERENCES

  • American College of Obstetricians and Gynecologists. 2009. Informed Consent. ACOG Committee Opinion No. 439. Obstetrics and Gynecology 114(2): 401–408.
  • Andrade, S., J. Gurwitz, R.L. Davis, et al. 2004. Prescription drug use in pregnancy. American Journal of Obstetrics & Gynecology 191(2): 398–407.
  • Andrade, S.E., M.A. Raebel, J. Brown, et al. 2008. Use of antidepressant medications during pregnancy: a multisite study. American Journal of Obstetrics & Gynecology 198(2): 194.e1–194.e5.
  • Byatt, N., K.M. Deligiannidis, and M.P. Freeman. 2013. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatrica Scandinavica 127(2): 94–114.
  • Centers for Disease Control and Prevention. 2009. Maternal and Infant Health Research: Pregnancy Complications. May 13. . Available at: http://www.cdc.gov/reproductivehealth//maternalinfanthealth/PregComplications.htm (accessed June 15, 2010).
  • Charo, R.A. 1993. Protecting us to death: Women, pregnancy, and clinical research trials. Saint Louis University Law Journal 38(1): 135–187.
  • Chervenak, F.A., and L.B. McCullough 2011. An ethically justified framework for clinical investigation to benefit pregnant and fetal patients. American Journal of Bioethics 11(5): 39–49.
  • Coverdale, J.H., L.B. McCullough, and F.A. Chervenak. 2008. The ethics of randomized placebo-controlled trials of antidepressants with pregnant women: a systematic review. Obstetrics & Gynecology 112(6): 1361–1368.
  • Gatny, H.H. and W.G. Axinn. 2011. Willingness to participate in research during pregnancy: race, experience, and motivation. Field Methods 24(2): 135–154.
  • Haire, D. 2001. FDA approved obstetrics drugs: Their effects on mother and baby. Pregnancy Information. . Available at: http://www.aimsusa.org/obstetricdrugs.htm (accessed September 9, 2013).
  • Healy, D. 2012. Herding women. . Available at: http://davidhealy.org/herding-women 2012.
  • Hurley, E., M. Little, and K. L. Winser. 2013. Overcoming obstacles to research with pregnant women. Public Responsibility in Medicine and Research (PRIM&R) Webinar. . Available at: http://www.primr.org/Conferences.aspx?id=17183.
  • Hyder, A.A., and L. Dawson. 2005. Defining standard of care in the developing world: The intersection of international research ethics and health systems analysis. Developing World Bioethics 5(2): 142–152.
  • Jetter, A. 2009. Pregnant pause. Vogue May: 144–232.
  • Koren, G., and H. Nordeng. 2012. Antidepressant use during pregnancy: The benefit–risk ratio. American Journal of Obstetrics & Gynecology 207(3): 157–163.
  • Kupfer, D.J., and E. Frank. 2002. Placebo in clinical trials for depression: Complexity and necessity. Journal of the American Medical Association 287(14): 1853–1854.
  • Lei, H., I. Nahum-Shani, K. Lynch, D. Oslin, and S.A. Murphy. 2012. A “SMART” design for building individualized treatment sequences. Annual Review of Clinical Psychology 8: 21–48.
  • Lo, W.Y., and J.M. Friedman. 2002. Teratogenicity of recently introduced medications in human pregnancy. Obstetrics & Gynecology 100(3): 465–473.
  • Lyerly, A.D., M.O. Little, and R. Faden 2008. The second wave: Toward responsible inclusion of pregnant women in research. International Journal of Feminist Approaches to Bioethics 1(2): 5–22.
  • Lyerly, A.D., M.O. Little, and R. Faden. 2011. Reframing the framework: Toward fair inclusion of pregnant women as participants in research. American Journal of Bioethics 11(5): 50–52.
  • Lyerly, A.D., L.M. Mitchell, E.M. Armstrong, et al. 2009. Risk and the pregnant body. Hastings Center Report 39(6): 34–42.
  • Lyerly, A.D., E.E. Namey, B. Gray, G. Swamy, and R.R. Faden. 2012. Women's views about participating in research while pregnant. IRB: Ethics and Human Research 34(4): 1–8.
  • Macklin, R. 2010. Enrolling pregnant women in biomedical research. Lancet 375(9715): 632–633.
  • Mattison, D., and A. Zajicek. 2006. Gaps in knowledge in treating pregnant women. Gender Medicine 3(3): 169–182.
  • McCullough, L.B., J.H. Coverdale, and F.A. Chervenak. 2005. A comprehensive ethical framework for responsibly designing and conducting pharmacologic research that involves pregnant women. American Journal of Obstetrics and Gynecology 193(3 Pt 2): 901–907.
  • Merkatz, R.B., and S.W. Junod. 1994. Historical background of changes in FDA policy on the study and evaluation of drugs in women. Academic Medicine 69(9): 703–707.
  • Miller, F.G., and H. Brody. 2002. What makes placebo-controlled trials unethical? American Journal of Bioethics 2(2): 3–9.
  • Miller, F.G., and H.J. Silverman. 2004. The ethical relevance of the standard of care in the design of clinical trials. American Journal of Respiratory and Critical Care Medicine 169(5): 562–564.
  • Mitchell, A.A., S.M. Gilboa, M.M. Werler, K.E. Kelley, C. Louik, and S. Hernández-Díaz. 2011. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. American Journal of Obstetetrics and Gynecology 205(1):. 51.e1–8.
  • Mohanna, K., and K. Tunna. 1999. Withholding consent to participate in clinical trials: Decisions of pregnant women. British Journal of Obstetrics and Gynaecology 106(9): 892–897.
  • Munk-Olsen, T., T.M. Laursen, C.B. Pederson, O. Mors, and P.B. Mortensen. 2006. New parents and mental disorders: A population-based register study. Journal of the American Medical Association 296(21): 2582–2589.
  • Murphy, S.A. 2005. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine 24(10): 1455–1481.
  • Norwitz, E.R., and J.A. Greenberg. 2011. FDA approval for use of medications in pregnancy: an uphill battle. Reviews in Obstetrics & Gynecology 4(2): 39–41.
  • Parsons, J.A., T.P. Johnson, R.B. Warnecke, and A. Kaluzny. 1993. The effect of interviewer characteristics on gatekeeper resistance in surveys of elite populations. Evaluation Review 17(2): 131–143.
  • Patel, S.R., and K.L. Wisner. 2011. Decision making for depression treatment during pregnancy and the postpartum period. Depression and Anxiety 28(7): 589–595.
  • Pinn, V.W., C. Roth, A.C. Bates, R. Wagner, and K. Jarema. 2009. Comprehensive report: Tracking of human subjects research as reported in fiscal year 2007 and fiscal year 2008. Monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research. Washington, DC : National Institutes of Health.
  • Qiu, X., J. He, l. Qui, C.P. Larson, H. Xia, and K.H. Lam. 2013. Willingness of pregnant women to participate in a birth cohort study in China. International Journal of Obstretrics and Gynecology 122(3): 216–218.
  • Robertson, J. 1999. Ethical issues related to the inclusion of pregnant women in clinical trials (I). In Women and health research: Ethical and legal issues of including women in clinical studies, vol. 2, ed. A. Mastroianni, R. Faden, and D. Federman, 18–22. Washington, DC : National Academies Press.
  • Rodger, M.A., D. Makropoulos, M. Walker, E. Keely, A. Karovitch, and P.S. Wells. 2003. Participation of pregnant women in clinical trials: Will they participate and why? American Journal of Perinatology 20(2): 69–76.
  • Second Wave Initiative. 2009. The second wave initiative: Toward the responsible inclusion of pregnant women in medical research. . Available at: http://www.secondwaveinitiative.org
  • Second Wave Workshop. 2009. The second wave: Toward the responsible inclusion of pregnant women in medical research. April 29–30. . Available at: http://kennedyinstitute.georgetown.edu/secondwave/participants.htm.
  • Sengupta, S., B. Lo, R.P. Strauss, J. Eron, and A.L. Gifford. 2010. How researchers define vulnerable populations in HIV/AIDS clinical trials. AIDS and Behavior 14(6): 1313–1319.
  • Steinbock, B. 1999. Ethical issues related to the inclusion of pregnant women in clinical trials (II). In Women and health research: Ethical and legal issues of including women in clinical studies, vol. 2, ed. A. Mastroianni, R. Faden, and D. Federman, 23–28. Washington, DC : National Academies Press.
  • U.S. Department of Health and Human Services. 2009. 45 CFR Part 46, Subpart B. . Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html (accessed March 6, 2014).
  • U.S. Department of Health and Human Services, Public Health Service, National Institues of Health, Office of Research on Women's Health. 2011. Enrolling pregnant women: Issues in clinical research. Bethesda, MD : National Institutes of Health. . Available at: http://orwh.od.nih.gov/resources/policyreports/pdf/ORWH-EPW-Report-2010.pdf
  • van der Graaf, R., and J.J. van Delden. 2009. What is the best standard for the standard of care in clinical research? American Journal of Bioethics 9(3): 35–43.
  • Wisner, K.L., P.S. Appelbaum, K. Uhl, and S.F. Goldkind. 2009. Pharmacotherapy for depressed pregnant women: Overcoming obstacles to gathering essential data. Clinical Pharmacology and Therapeutics 86(4): 362–365.
  • Wisner, K.L., C. Chambers, and D.K. Y. Sit. 2006. Postpartum depression: A major public health problem. Journal of the American Medical Association 296(21): 2616–2618.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.